Provider review

TMates reviewed

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

TMates scores 45.2 out of 100 on our published Value Score formula for tirzepatide. It charges $297 a month all-in at 10 mg/week, and raises the price as the dose rises.

What it wins

It holds no computed category at this build. For reference, NexLife, our #1 pick, charges $129 a month for tirzepatide at every dose (as of November 6, 2026).

Where it sits on tirzepatide

TMates is number 12 of 27 rankable tirzepatide programs on all-in monthly cost, at $297. The program immediately below it is Found Official site at $289, $8 cheaper. The next one up is OrderlyMeds Official site at $299.

$96 a year separates them. What does TMates disclose that Found does not? Neither names its compounding pharmacy, so the premium is not buying disclosure. Full head-to-head.

TMates charges a flat $297 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.

2.557.51012.515mg/week$297$297
Tirzepatide holds at $297 a month across every dose — a flat line. 4 of 6 doses have no published price; those gaps are shown as gaps.

The gaps matter more than the headline. TMates publishes nothing at 5, 7.5, 12.5, 15 mg per week, so a reader cannot establish what the middle of a titration costs without asking. We leave those blank rather than interpolating.

How TMates ranks at each rung of the tirzepatide ladder
DoseTMates priceRank at this doseField median at this dose
2.5 mg$29716 of 31$297
5 mgnot published——
7.5 mgnot published——
10 mg$29712 of 27$299
12.5 mgnot published——
15 mgnot published——

Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.

Where it sits on semaglutide

TMates is number 18 of 29 rankable semaglutide programs on all-in monthly cost, at $249. The program immediately below it is ShedRx Official site at $249, the same price. The next one up is Luvo Health Official site at $249.

$0 a year separates them. What does TMates disclose that ShedRx does not? Neither names its compounding pharmacy, so the premium is not buying disclosure. Full head-to-head.

TMates charges a flat $249 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.

0.250.511.72.4mg/week$249$249
Semaglutide holds at $249 a month across every dose — a flat line. 3 of 5 doses have no published price; those gaps are shown as gaps.

The gaps matter more than the headline. TMates publishes nothing at 0.5, 1, 1.7 mg per week, so a reader cannot establish what the middle of a titration costs without asking. We leave those blank rather than interpolating.

How TMates ranks at each rung of the semaglutide ladder
DoseTMates priceRank at this doseField median at this dose
0.25 mg$24921 of 32$199
0.5 mgnot published——
1 mgnot published——
1.7 mgnot published——
2.4 mg$24918 of 29$199

Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.

What would move it

11 programs are priced below it on tirzepatide. Reaching the three lowest all-in tirzepatide prices on record would take a price at or under $179 a month — a cut of $118 from where it stands. Alternatively, an independent checkout capture would lift its evidence component without any price change.

Why it scores what it does

Of 45.2 points, 29.7 of a possible 70 come from price measured against the $126 category floor, 10.5 of 15 from evidence status (reported), 0 of 10 from dose policy and 5 of 5 from membership. Its weakest component is its dose policy.

The evidence term is worth dwelling on. TMates's figure is reported — sourced from dated third-party reporting; first-party capture pending. An independent checkout capture would raise that component without the price changing at all, so this score is a floor rather than a ceiling.

What you are actually buying

TMates carries no separate membership fee, shipping included, commitment terms of 12-month plan or month-to-month; substantial difference in rates, cancellation on Per provider terms.

It does not name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who makes the medication cannot be verified. Availability is stated as Confirm at intake.

Against the field

29 of 36 programs charge no membership, 8 name their pharmacy, 19 price flat. TMates: no membership, pharmacy unnamed, priced by dose.

What to establish before enrolling

Drawn from what this specific record does not contain:

  • What tirzepatide costs at 5, 7.5, 12.5, 15 mg per week.
  • What semaglutide costs at 0.5, 1, 1.7 mg per week.
  • Which compounding pharmacy fills the prescription, in writing.
  • Whether the program is licensed to ship to your state.
  • The exact cancellation notice period and refund terms.

In writing, before you pay.

On the record: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.

Who should pick it, and who should not

Consider TMates if you want to be able to pause without a fee continuing.

Look elsewhere if you expect to settle at a high dose, because the price rises with the dose; verifying who makes the medication matters to you, because the pharmacy is not named; price is your main criterion, since it runs $171 a month above the category floor.

At $297 a month it is $168 above NexLife's $129, the price of our #1 pick — $2,016 a year for what it discloses and includes.

Questions

Is TMates worth it?

At $297 a month all-in it scores 45.2 out of 100 on our published formula, against a category floor of $126. Whether that is worth it depends on whether its dose policy, pharmacy disclosure and cancellation terms justify the gap — the review above lays out both sides.

How much does TMates cost in total?

$297 a month all-in at 10 mg/week, or $2,004 across twelve months on a prepaid term. All-in means the medication plus every mandatory recurring fee.

What is cheaper than TMates?

The next program below it on all-in monthly tirzepatide cost is Found at $289 a month, $8 less per month. TMates ranks 12 of 27 on price.

Is TMates legitimate?

This site takes no position on any company's legitimacy. What we can report is that TMates does not publicly name its compounding pharmacy, so its licensing and inspection history cannot be checked independently. That is a disclosure gap, not a finding of wrongdoing.

How do I cancel TMates?

Per provider terms

Figures from the TMates record, dataset v2026-11-10. TMates official site. Prices change; verify at checkout. Compounded tirzepatide and semaglutide are not FDA-approved products.